WO2012040083A1 - Auto injector for medication - Google Patents

Auto injector for medication Download PDF

Info

Publication number
WO2012040083A1
WO2012040083A1 PCT/US2011/052101 US2011052101W WO2012040083A1 WO 2012040083 A1 WO2012040083 A1 WO 2012040083A1 US 2011052101 W US2011052101 W US 2011052101W WO 2012040083 A1 WO2012040083 A1 WO 2012040083A1
Authority
WO
WIPO (PCT)
Prior art keywords
medication
cartridge
drug
insulin
patient
Prior art date
Application number
PCT/US2011/052101
Other languages
French (fr)
Other versions
WO2012040083A8 (en
Inventor
Sean M. O'connor
Luis G. Jahn
Original Assignee
Animas Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Animas Corporation filed Critical Animas Corporation
Priority to BR112013008677A priority Critical patent/BR112013008677A2/en
Priority to CA2811800A priority patent/CA2811800A1/en
Priority to JP2013529392A priority patent/JP5925784B2/en
Priority to CN2011800454808A priority patent/CN103118724A/en
Priority to EP11827286.3A priority patent/EP2618871A4/en
Priority to AU2011305705A priority patent/AU2011305705A1/en
Publication of WO2012040083A1 publication Critical patent/WO2012040083A1/en
Publication of WO2012040083A8 publication Critical patent/WO2012040083A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1454Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons spring-actuated, e.g. by a clockwork
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14566Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M2005/14268Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with a reusable and a disposable component
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581Means for facilitating use, e.g. by people with impaired vision by audible feedback

Definitions

  • the present invention relates, in general, to drug delivery devices and, more particularly, to auto-injection devices for medications.
  • Diabetes is a major health concern, as it can significantly impede on the freedom of action and lifestyle of persons afflicted with this disease.
  • treatment of the more severe form of the condition, Type I (insulin-dependent) diabetes requires one or more insulin injections per day, referred to as multiple daily injections.
  • Insulin is required to control glucose or sugar in the blood, thereby preventing hyperglycemia that, if left uncorrected, can lead to ketosis. Additionally, improper administration of insulin therapy can result in hypoglycemic episodes, which can cause coma and death.
  • Hyperglycemia in diabetics has been correlated with several long-term effects of diabetes, such as heart disease, atherosclerosis, blindness, stroke, hypertension, and kidney failure.
  • such devices permit the patient to quickly, and with a minimal amount of physical discomfort, obtain a sample of their blood or interstitial fluid that is then analyzed by the meter.
  • the meter has a display screen that shows the BG reading for the patient.
  • the patient may then dose theirselves with the appropriate amount, or bolus, of insulin. For many diabetics, this results in having to receive multiple daily injections of insulin. In many cases, these injections are self- administered.
  • BG levels due to the debilitating effects that abnormal BG levels can have on patients, i.e., hyperglycemia, persons experiencing certain symptoms of diabetes may not be in a situation where they can safely and accurately self-administer a bolus of insulin.
  • persons with active lifestyles find it extremely inconvenient and imposing to have to use multiple daily injections of insulin to control their blood sugar levels, as this may interfere or prohibit their ability to engage in certain activities.
  • multiple daily injections may simply not be the most effective means for controlling their BG levels.
  • insulin infusion pumps have been developed.
  • Insulin pumps are generally devices that are worn on the patient's body, either above or below their clothing. Because the pumps are worn on the patient's body, a small and unobtrusive device is desirable. Therefore, it would be desirable for patients to have a more compact drug delivery device that delivers medication reliably and accurately. Further, it would be desirable for such devices to provide improved performance, ease of use, and reduced pain to those requiring large quantities of injected medications.
  • Figure 1 illustrates an exemplary embodiment of an auto-injector device in
  • Figure 2 illustrates another exemplary embodiment of an auto-injector device according to the present invention in three instances as the amount of fluid in the drug reservoir is reduced.
  • the invention relates to an injection device, also called an auto-injector, for delivering medication to a patient.
  • an injection device also called an auto-injector
  • patients have been given medication via needles and syringes.
  • intravenous "drips" have been used, but such devices typically require a trained healthcare provider, such as a nurse or doctor to ensure that the infusion device is correctly inserted through the skin of the patient.
  • the medication is often mixed with a saline solution for delivery to the patient over a period of hours or longer.
  • an exemplary structure for such a device many comprise, consist of, or consist essentially of a housing 100 that has a cavity 105 therein. Within the cavity 105 may be disposed a cartridge 140 containing a quantity of medication. At one end, the cartridge has a septuml45 for receiving an infusion device 150. At the other end, the cartridge 140 receives a plunger 135 that is biased by one or more springs 130.
  • the springs may be replaced by worm drives, lead screws, or other devices that can be configured to elongate at a predetermined rate, to bias the plunger 135 into the cartridge 140 to eject medication via the septum 145 and through the infusion device 150 and ultimately into the patient.
  • springs it is desirable to minimize the length of the cartridge 140 to maintain substantially linear spring force travel. While small variations in spring force will not substantially negatively affect the delivery of medication, it is desirable that the rate of drug delivery be maintained as substantially constant until the cartridge is empty.
  • the device may also contain an activation tab 1 10 that separates the septum 145 from the infusion device 150. Pulling the activation tab 1 10 allows the infusion device 150 to pierce the septum 145 and begin drug delivery into the patient. Once the drug reservoir in the cartridge is exhausted, the device may be discarded. Alternatively, the device may include means for inserting a full cartridge or refilling the cartridge. A sight window 120 may be provided to allow the user to visually determine whether drug remains in the cartridge. As well, although not shown in the figures, another spring or set of springs may be included to bias the infusion set through the septum 145 when the activation tab 1 10 is removed.
  • FIG. 2 illustrates another embodiment of the invention in which the plunger 220 has a protrusion 230.
  • the interior of the housing 200 includes a post 210 placed adjacent to a leaf spring 220 or similarly flexible member (which could be as simple as a soft plastic protrusion).
  • the protrusion 230 nears the leaf spring 220.
  • the protrusion 230 biases the leaf spring 220 and when the cartridge is empty (or drug delivery is complete), the protrusion 230 passes the leaf spring 220, causing the leaf spring 220 to recoil and impact against the post 210.
  • the size of the cartridge will be determined by the amount of medication that the patient requires with each injection. With insulin, typical cartridges may range from 50 units (0.5ml) to 300 units (3ml).
  • the spring force necessary to deliver the medication via the infusion device is dependent on the viscosity of the drug in the cartridge and the desired delivery time. For example, a viscous drug delivered over a short period of time will require a spring system with higher force than a relatively low viscosity drug to be delivered over a long period of time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Described is drug infusion device. The device is intended to permit the delivery of medication over an extended period of time. An exemplary device for injecting medication may comprise: a housing; a cavity configured to accept a drug cartridge; a plunger configured to interact with the drug cartridge; at least one biasing spring biased against an inner surface of the cavity and the plunger; and an infusion device configured to carry fluid from the drug cartridge to a catheter.

Description

AUTO INJECTOR FOR MEDICATION
Possible Inventors: Sean O'Connor, Luis Jahn
FIELD OF THE INVENTION
[001] CROSS REFERENCE TO RELATED APPLICATIONS
This application relates to U.S. patent application Ser. No. 61/384,871, filed September 21, 2010; all applications are herein incorporated by reference in their entireties.
[002] The present invention relates, in general, to drug delivery devices and, more particularly, to auto-injection devices for medications.
BACKGROUND OF THE INVENTION
[003] The use of drug delivery devices for various types of drug therapy is becoming more common as the automated infusion of a drug may provide more reliable and more precise treatment to a patient.
[004] Diabetes is a major health concern, as it can significantly impede on the freedom of action and lifestyle of persons afflicted with this disease. Typically, treatment of the more severe form of the condition, Type I (insulin-dependent) diabetes, requires one or more insulin injections per day, referred to as multiple daily injections. Insulin is required to control glucose or sugar in the blood, thereby preventing hyperglycemia that, if left uncorrected, can lead to ketosis. Additionally, improper administration of insulin therapy can result in hypoglycemic episodes, which can cause coma and death. Hyperglycemia in diabetics has been correlated with several long-term effects of diabetes, such as heart disease, atherosclerosis, blindness, stroke, hypertension, and kidney failure.
[005] The value of frequent monitoring of blood glucose as a means to avoid or at least minimize the complications of Type I diabetes is well established. Patients with Type II (non- insulin-dependent) diabetes can also benefit from blood glucose monitoring in the control of their condition by way of diet and exercise. Thus, careful monitoring of blood glucose levels and the ability to accurately and conveniently infuse insulin into the body in a timely manner is a critical component in diabetes care and treatment. [006] To more effectively control diabetes in a manner that reduces the limitations imposed by this disease on the lifestyle of the affected person, various devices for facilitating blood glucose (BG) monitoring have been introduced. Typically, such devices, or meters, permit the patient to quickly, and with a minimal amount of physical discomfort, obtain a sample of their blood or interstitial fluid that is then analyzed by the meter. In most cases, the meter has a display screen that shows the BG reading for the patient. The patient may then dose theirselves with the appropriate amount, or bolus, of insulin. For many diabetics, this results in having to receive multiple daily injections of insulin. In many cases, these injections are self- administered.
[007] Due to the debilitating effects that abnormal BG levels can have on patients, i.e., hyperglycemia, persons experiencing certain symptoms of diabetes may not be in a situation where they can safely and accurately self-administer a bolus of insulin. Moreover, persons with active lifestyles find it extremely inconvenient and imposing to have to use multiple daily injections of insulin to control their blood sugar levels, as this may interfere or prohibit their ability to engage in certain activities. For others with diabetes, multiple daily injections may simply not be the most effective means for controlling their BG levels. Thus, to further improve both accuracy and convenience for the patient, insulin infusion pumps have been developed.
[008] Insulin pumps are generally devices that are worn on the patient's body, either above or below their clothing. Because the pumps are worn on the patient's body, a small and unobtrusive device is desirable. Therefore, it would be desirable for patients to have a more compact drug delivery device that delivers medication reliably and accurately. Further, it would be desirable for such devices to provide improved performance, ease of use, and reduced pain to those requiring large quantities of injected medications.
BRIEF DESCRIPTION OF THE DRAWINGS
[009] The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
[010] Figure 1 illustrates an exemplary embodiment of an auto-injector device in
perspective, cutaway view.
[011] Figure 2 illustrates another exemplary embodiment of an auto-injector device according to the present invention in three instances as the amount of fluid in the drug reservoir is reduced.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS OF THE
INVENTION
[012] The invention relates to an injection device, also called an auto-injector, for delivering medication to a patient. For many years, patients have been given medication via needles and syringes. In instances where large quantities of medication must be delivered over an extended period of time, intravenous "drips" have been used, but such devices typically require a trained healthcare provider, such as a nurse or doctor to ensure that the infusion device is correctly inserted through the skin of the patient. Further, the medication is often mixed with a saline solution for delivery to the patient over a period of hours or longer.
[013] Presently, inadequate devices exist to permit individuals, such as insulin-dependent diabetics, to safely self-administer the often large quantity of medication that they require on a daily or multiple-daily basis. Typically, such diabetics must inject their medication via a syringe over a period of 10-30 minutes (or longer) using a needle that pierces their dermal tissue. Often, due to the pain associated with these injections, the patient will attempt to "rush" delivery of their medication, further increasing their pain and forcing their medication to disperse through the dermal tissue due to the large size of insulin molecules and the high viscosity of the drug. Moreover, it is often beneficial from a therapeutic standpoint for insulin dependent diabetics to receive their injections over an extended period of time.
[014] Given this need, it has been found that a device that is capable of storing a large quantity of medication and delivering it over an extended period of time can be therapeutically beneficial to patients with many afflictions, particularly diabetes. As shown in Figure 1, an exemplary structure for such a device many comprise, consist of, or consist essentially of a housing 100 that has a cavity 105 therein. Within the cavity 105 may be disposed a cartridge 140 containing a quantity of medication. At one end, the cartridge has a septuml45 for receiving an infusion device 150. At the other end, the cartridge 140 receives a plunger 135 that is biased by one or more springs 130.
[015] Those skilled in the art will recognize that the springs may be replaced by worm drives, lead screws, or other devices that can be configured to elongate at a predetermined rate, to bias the plunger 135 into the cartridge 140 to eject medication via the septum 145 and through the infusion device 150 and ultimately into the patient. When springs are used, it is desirable to minimize the length of the cartridge 140 to maintain substantially linear spring force travel. While small variations in spring force will not substantially negatively affect the delivery of medication, it is desirable that the rate of drug delivery be maintained as substantially constant until the cartridge is empty.
[016] The device may also contain an activation tab 1 10 that separates the septum 145 from the infusion device 150. Pulling the activation tab 1 10 allows the infusion device 150 to pierce the septum 145 and begin drug delivery into the patient. Once the drug reservoir in the cartridge is exhausted, the device may be discarded. Alternatively, the device may include means for inserting a full cartridge or refilling the cartridge. A sight window 120 may be provided to allow the user to visually determine whether drug remains in the cartridge. As well, although not shown in the figures, another spring or set of springs may be included to bias the infusion set through the septum 145 when the activation tab 1 10 is removed.
[017] Figure 2 illustrates another embodiment of the invention in which the plunger 220 has a protrusion 230. The interior of the housing 200 includes a post 210 placed adjacent to a leaf spring 220 or similarly flexible member (which could be as simple as a soft plastic protrusion). As the plunger 220 moves as a result of the biasing of the one or more springs 240, the protrusion 230 nears the leaf spring 220. As the cartridge nears exhaustion, the protrusion 230 biases the leaf spring 220 and when the cartridge is empty (or drug delivery is complete), the protrusion 230 passes the leaf spring 220, causing the leaf spring 220 to recoil and impact against the post 210. The concussive force of the impact causes an audible "click" to indicate to the user that drug delivery is complete and the device may be removed. [018] It will be recognized that equivalent structures may be substituted for the structures illustrated and described herein and that the described embodiment of the invention is not the only structure, which may be employed to implement the claimed invention. In addition, it should be understood that every structure described above has a function and such structure can be referred to as a means for performing that function. While embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention.
[019] Typically, the size of the cartridge will be determined by the amount of medication that the patient requires with each injection. With insulin, typical cartridges may range from 50 units (0.5ml) to 300 units (3ml). The spring force necessary to deliver the medication via the infusion device is dependent on the viscosity of the drug in the cartridge and the desired delivery time. For example, a viscous drug delivered over a short period of time will require a spring system with higher force than a relatively low viscosity drug to be delivered over a long period of time.
[020] It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims

CLAIMS WHAT IS CLAIMED IS:
1. A device for injecting medication, comprising:
a housing;
a cavity configured to accept a drug cartridge;
a plunger configured to interact with the drug cartridge;
at least one biasing spring biased against an inner surface of the cavity and the plunger; and
an infusion device configured to carry fluid from the drug cartridge to a catheter.
PCT/US2011/052101 2010-09-21 2011-09-19 Auto injector for medication WO2012040083A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BR112013008677A BR112013008677A2 (en) 2010-09-21 2011-09-19 autoinjector for medication
CA2811800A CA2811800A1 (en) 2010-09-21 2011-09-19 Auto injector for medication
JP2013529392A JP5925784B2 (en) 2010-09-21 2011-09-19 Automatic medicine injection device
CN2011800454808A CN103118724A (en) 2010-09-21 2011-09-19 Auto injector for medication
EP11827286.3A EP2618871A4 (en) 2010-09-21 2011-09-19 Auto injector for medication
AU2011305705A AU2011305705A1 (en) 2010-09-21 2011-09-19 Auto injector for medication

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38487110P 2010-09-21 2010-09-21
US61/384,871 2010-09-21
US13/233,525 2011-09-15
US13/233,525 US20120071837A1 (en) 2010-09-21 2011-09-15 Auto injector for medication

Publications (2)

Publication Number Publication Date
WO2012040083A1 true WO2012040083A1 (en) 2012-03-29
WO2012040083A8 WO2012040083A8 (en) 2013-04-25

Family

ID=45818387

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/052101 WO2012040083A1 (en) 2010-09-21 2011-09-19 Auto injector for medication

Country Status (9)

Country Link
US (1) US20120071837A1 (en)
EP (1) EP2618871A4 (en)
JP (1) JP5925784B2 (en)
CN (1) CN103118724A (en)
AU (1) AU2011305705A1 (en)
BR (1) BR112013008677A2 (en)
CA (1) CA2811800A1 (en)
TW (1) TW201226001A (en)
WO (1) WO2012040083A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240136476A (en) 2015-03-10 2024-09-13 리제너론 파아마슈티컬스, 인크. Aseptic piercing system and method
EP3503948A1 (en) * 2016-08-26 2019-07-03 Sanofi-Aventis Deutschland GmbH Audible indicator
BR112019020705A2 (en) 2017-05-05 2020-05-12 Regeneron Pharmaceuticals, Inc. AUTOINJECTOR
USD1007676S1 (en) 2021-11-16 2023-12-12 Regeneron Pharmaceuticals, Inc. Wearable autoinjector

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346476A (en) * 1992-04-29 1994-09-13 Edward E. Elson Fluid delivery system
US5954695A (en) * 1995-08-24 1999-09-21 The General Hospital Corporation Multi-dose syringe driver

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9610374B (en) * 1995-12-11 1997-06-23 Elan Med Tech Cartridge-based drug delivery device
JPH10248928A (en) * 1997-03-11 1998-09-22 Terumo Corp Medical fluid supply jig and priming device
US7611495B1 (en) * 2005-10-07 2009-11-03 Gianturco Michael C Device for manually controlling delivery rate of a hypodermic syringe and syringe having same
DE102007031630B3 (en) * 2007-07-06 2008-12-24 Lts Lohmann Therapie-Systeme Ag Disposable injector with at least one support rod

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346476A (en) * 1992-04-29 1994-09-13 Edward E. Elson Fluid delivery system
US5954695A (en) * 1995-08-24 1999-09-21 The General Hospital Corporation Multi-dose syringe driver

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2618871A4 *

Also Published As

Publication number Publication date
EP2618871A4 (en) 2014-04-02
CA2811800A1 (en) 2012-03-29
JP2013537098A (en) 2013-09-30
JP5925784B2 (en) 2016-05-25
AU2011305705A1 (en) 2013-05-02
EP2618871A1 (en) 2013-07-31
TW201226001A (en) 2012-07-01
US20120071837A1 (en) 2012-03-22
CN103118724A (en) 2013-05-22
BR112013008677A2 (en) 2016-06-21
WO2012040083A8 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
US20130090605A1 (en) Tunable mechanical injection device for medication
JP6581110B2 (en) Catheter insertion mechanism for patch pump
US11471592B2 (en) Extended use medical device
US10130759B2 (en) Multi-ported drug delivery device having multi-reservoir cartridge system
EP2978474B1 (en) Fluid cartridge for medical infusion device
JP6685236B2 (en) Catheter insertion device
EP2105153A2 (en) Medical device mechanical pump
US20160136355A1 (en) Medical infusion pump mechanism
EP2236164B1 (en) Insulin cartridge cap
CA2642176C (en) Drug delivery system with cartridge interlock
US20120071837A1 (en) Auto injector for medication
JP6032892B2 (en) Cartridge stopper for intradermal administration system
Robertson et al. The latest developments in insulin injection devices
JP2024524238A (en) - User removable filling closure tab and integrated membrane
EP2047875A2 (en) Drug delivery system with breakaway plunger extractor
EP2168617B1 (en) Spring-loaded cartridge cap
Ahmed et al. INSULIN DEVICES AND REGIMENS.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180045480.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11827286

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2013529392

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2811800

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011827286

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2011305705

Country of ref document: AU

Date of ref document: 20110919

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013008677

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013008677

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130320